Chlorogenic acid, a natural product as potential inhibitor of COVID-19: virtual screening experiment based on network pharmacology and molecular docking
WX Wang, YR Zhang, SY Luo, YS Zhang… - Natural Product …, 2022 - Taylor & Francis
Chlorogenic acid (CGA) is a potential inhibitor of Coronavirus Disease 2019 (COVID-19).
ACE2 and its co-expressed proteins are SARS-CoV-2 receptors, which have been linked to …
ACE2 and its co-expressed proteins are SARS-CoV-2 receptors, which have been linked to …
Screening for a Potential Therapeutic Agent from the Herbal Formula in the 4th Edition of the Chinese National Guidelines for the Initial‐Stage Management of COVID …
Background. COVID‐19 caused by SARS‐CoV‐2 infection has been spreading through
many countries since the end of 2019. The 4th edition of the national guidelines for the …
many countries since the end of 2019. The 4th edition of the national guidelines for the …
Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and …
J Wang, W Ge, X Peng, L Yuan, S He, X Fu - Molecular Diversity, 2021 - Springer
Traditional Chinese medicine (TCM) has exerted positive effects in controlling the COVID-19
pandemic. HuaShi XuanFei Formula (HSXFF) was developed to treat patients with mild and …
pandemic. HuaShi XuanFei Formula (HSXFF) was developed to treat patients with mild and …
Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19
Q Tao, J Du, X Li, J Zeng, B Tan, J Xu… - Drug development and …, 2020 - Taylor & Francis
Abstract Purpose Huashi Baidu formula (HSBDF) was developed to treat the patients with
severe COVID-19 in China. The purpose of this study was to explore its active compounds …
severe COVID-19 in China. The purpose of this study was to explore its active compounds …
Geranii Herba as a Potential Inhibitor of SARS-CoV-2 Main 3CLpro, Spike RBD, and Regulation of Unfolded Protein Response: An In Silico Approach
Background: Since the first patient identified with SARS-CoV-2 symptoms in December
2019, the trend of a spreading coronavirus disease 2019 (COVID-19) infection has …
2019, the trend of a spreading coronavirus disease 2019 (COVID-19) infection has …
Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting Mpro and Sepsis in Mice
T Xiao, M Cui, C Zheng, P Zhang, S Ren, J Bao, D Gao… - Inflammation, 2022 - Springer
The emergence of severe acute syndrome coronavirus 2 (SARS-CoV-2) in December 2019
has led to the global COVID-19 pandemic. Although the symptoms of most COVID-19 …
has led to the global COVID-19 pandemic. Although the symptoms of most COVID-19 …
[HTML][HTML] Chinese herbal compounds against SARS-CoV-2: puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor
B Pan, S Fang, J Zhang, Y Pan, H Liu, Y Wang… - Computational and …, 2020 - Elsevier
The outbreak of COVID-19 raises an urgent need for the therapeutics to contain the
emerging pandemic. However, no effective treatment has been found for SARS-CoV-2 …
emerging pandemic. However, no effective treatment has been found for SARS-CoV-2 …
[HTML][HTML] Exploring the active compounds of traditional Mongolian medicine in intervention of novel coronavirus (COVID-19) based on molecular docking method
J Yu, L Wang, L Bao - Journal of functional foods, 2020 - Elsevier
Objective This article intends to use molecular docking technology to find potential inhibitors
that can respond to COVID-19 from active compounds in Mongolian medicine. Methods …
that can respond to COVID-19 from active compounds in Mongolian medicine. Methods …
[HTML][HTML] Luteolin is a potential inhibitor of COVID-19: An in silico analysis
W Wang, C Yang, J Xia, N Li, W Xiong - Medicine, 2023 - journals.lww.com
The severe respiratory syndrome 2019 novel coronavirus disease (COVID-19) caused by
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread explosively …
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread explosively …
Network pharmacology and molecular docking-based investigations of Kochiae Fructus's active phytomolecules, molecular targets, and pathways in treating COVID …
COVID-19 disease is caused by SARS-CoV-2. Hyper-inflammation mediated by
proinflammatory cytokines is humans' primary etiology of SARS-CoV-2 infection. Kochiae …
proinflammatory cytokines is humans' primary etiology of SARS-CoV-2 infection. Kochiae …
相关搜索
- covid 19 network pharmacology
- covid 19 molecular docking
- molecular docking network pharmacology
- covid 19 chlorogenic acid
- chlorogenic acid network pharmacology
- chlorogenic acid molecular docking
- screening experiment network pharmacology
- screening experiment molecular docking
- covid 19 screening experiment
- chlorogenic acid screening experiment
- virtual screening experiment
- covid 19 coronavirus disease
- coronavirus disease network pharmacology
- covid 19 active compounds
- covid 19 prevention and treatment
- covid 19 kochiae fructus